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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe collection sites of human primary tissue samples and the receiving laboratories, where the human induced pluripotent stem cells
(hIPSCs) are derived, are often not on the same site. Thus, the stability of samples prior to derivation constrains the distance between
the collection site and the receiving laboratory. To investigate sample stability, we collected blood and held it at room temperature for
5, 24, or 48 hr before isolating peripheral bloodmononuclear cells (PBMCs) and reprogramming into IPSCs. Additionally, PBMC samples
at 5- and 48-hr time points were frozen in liquid nitrogen for 4 months and reprogrammed into IPSCs. hIPSC lines derived from all time
points were pluripotent, displayed no marked difference in chromosomal aberration rates, and differentiated into three germ layers.
Reprogramming efficiency at 24- and 48-hr time points was 3- and 10-fold lower, respectively, than at 5 hr; the freeze-thaw process of
PBMCs resulted in no obvious change in reprogramming efficiency.INTRODUCTION
Adult somatic cells from patients can be now reprog-
rammed to a pluripotent state by the ectopic expression
of transcription factors such as OCT3/4, SOX2, KLF4, and
c-MYC (Takahashi et al., 2007).
Several large-scale initiatives have been launched to
fully explore the pharmaceutical and clinical potentials
of human induced pluripotent stem cells (hIPSCs) (Soares
et al., 2014). However, there are major challenges associ-
ated with large-scale production of hIPSC lines, including
the availability of somatic tissues and potential degrada-
tion of collected tissue during transportation and storage.
Furthermore, primary tissue collection from a diversity
of patients located in a variety of referral centers can be
difficult since it may require transportation over long
distances. Factors that affect the stability of biological
samples include temperature and time elapse before
samples can be processed in laboratories. Thus, any de-
lays between collection and processing can affect the
sample integrity, viability, and other factors necessary
for successful reprogramming. Such information remains
to be systematically gathered for the main cell types used
for generating hIPSC lines. Traditionally, hIPSCs are
derived from skin punch biopsies (Chen et al., 2011).
These are often assumed to be more traumatic for pa-
tients as local anesthesia and a stich may be required,
i.e., for 4-mm punch biopsies, and the procedure can660 Stem Cell Reports j Vol. 5 j 660–671 j October 13, 2015 j ª2015 The Aleave a scar. This may result in a decrease in the number
of volunteers for tissue donation. The derived fibroblasts
require a prolonged period of expansion in culture prior
to reprogramming. Moreover, concerns have been raised
over the potential risks of mutations associated with
exposure of epidermis to UV light (van der Pols et al.,
2006) and raises a clinical concern on the safety of
the IPSCs cells derived from skin (Loh et al., 2010). The
ideal somatic cell type for hIPSC derivation should be
easily accessible and require a less traumatic sampling
procedure.
Less traumatic, non-invasive methods of collecting cells
for reprogramming from blood, hair follicle, and urine
have been described (Raab et al., 2014). Each of these
methods has its advantages and disadvantages.
Peripheral blood is an advantageous alternative to skin
for hIPSC derivation (Loh et al., 2010; Zhang 2013) since
it is widely used in clinical diagnostics, and moreover, the
method of blood collection is standardized and relatively
less traumatic than skin biopsy.
In this study, we set out to establish the permissible time
during which blood samples can be stored at room tem-
perature after collection without severely compromising
their ability to be successfully reprogrammed into IPSCs.
We also assessed the capacity for self-renewal, differen-
tiation, and the genomic integrity and to ensure that
the derived IPSCs are of good quality for disease modeling
and clinical application.uthors
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Figure 1. Morphology and Flow Cytometry
Analysis of Blood Stability Time Points
PBMCs isolated from blood held at RT
for 5-, 24-, and 48 hr postcollection were
expanded into erythroblasts for 9 days in the
presence of growth factors.
(A) Representative phase-contrast images
of erythroblast-enriched population (donor
1: codr) with characteristic clustering
behavior in all the three stability time
points at day 9 postexpansion (scale bars
represent 250 mm).
(B and C) Erythroblast populations
expanded from blood samples held at RT
for 5-, 24-, and 48 hr postcollection were
detected by immunostaining with anti-
bodies specific for erythroid markers (CD71
and CD36) analyzed by flow cytometry.
Representative flow cytometry data of
donor 1 and donor 2 are shown.RESULTS
IPSCs Can Be Derived from Blood Samples Stored at
Room Temperature for up to 48 hr Postcollection
hIPSCs are routinely derived from fresh blood, but whether
hIPSCs with similar properties can be derived from long-
term-stored human peripheral blood remains to be evalu-
ated. We sought to examine the effects of blood stability
on reprogramming (Figure S1). Briefly, blood samples were
collected from two patients (3 3 10 ml for each donor)
and kept for 5, 24, or 48 hr at room temperature. Then
PBMCswere isolated fromeach sample and grown inmedia
favoring the expansion of the erythroid lineage for 9 days.Stem CellRepresentative images of expanded erythroblast of donor
1 displaying characteristic clustering behavior in all the
three stability timepoints (Figure 1A).Onday 9, postexpan-
sion cells were stained with CD71 and CD36 antibodies
specific for erythroid markers and analyzed for expression
by flow cytometry; 72.3% of cells expressed both markers,
indicating enrichment of erythroblasts for donor 1 (Fig-
ure 1B). Blood samples kept at room temperature for 24 or
48 hr display a lower capacity with 3- or 7.5-fold, respec-
tively, to produce CD71 and CD36 expressing erythroid
cells than blood samples kept at room temperature for
5 hr, confirming that long-term storage of primary samples
could be detrimental. A similar observation was made withReports j Vol. 5 j 660–671 j October 13, 2015 j ª2015 The Authors 661
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Figure 2. Reprogramming of Erythro-
blast-Enriched Populations
(A) Representative images in the top
show AP-stained IPSC colonies derived from
samples that had been held at room tem-
perature for 5-, 24-, and 48 hr postdraw.
Reprogramming efficiency was quantified by
determining the percentage of AP-positive
colonies (bottom).
(B) Representative phase-contrast images
of IPSCs with characteristic typical human
ES cell-like morphology in all the three
stability time points are shown. Donor 1
(codr), donor 2 (gabq). Scale bars represent
250 mm.
(C) Representative images show AP stained
IPSC colonies derived from two erythroblasts
donors (donor 1 and donor 2) that had been
held at room temperature for 5 hr postdraw
followed by a freeze and thaw cycle (linked
to Figure S2). Reprogramming efficiency was
quantified by determining the percentage of
AP-positive colonies.donor 2where the percentage of enriched erythroblast pop-
ulationwas also dramatically reduced to 4-fold with respect
to 24-hr incubation at room temperature compared with
5 hr (Figure 1C).
We next sought to determine whether the erythroblasts
obtained from these samples could produce IPSCs. Cells
were transduced with Sendai viruses expressing human
OCT3/4, SOX2, KLF4, and c-MYC at anMOI of 6 and result-
ing IPSC colonies stained with alkaline phosphatase (AP)
(Martı´ et al., 2013; Bar-Nur et al., 2015). Small IPSC colonies
became visible 2-weeks posttransduction in all the trans-
duced lines at each of the three stability time points.
However, consistent with our findings on PBMCs stability
by immunostaining with erythroblast marker, a decrease
in the number of IPSC colonies was observed for cells at
24- or 48-hr stability time points compared with samples
processed 5 hr postdraw (Figure 2A). Reprogramming effi-
ciencies ranging from 0.06% to 0.009% (donor 1) and662 Stem Cell Reports j Vol. 5 j 660–671 j October 13, 2015 j ª2015 The A0.05% to 0.0015% (donor 2) were observed for 5- to 48-hr
storage time points. As the enriched erythroblast popu-
lation of day 9 culture has not been purified, there is still
a possibility of reprogramming other cell lineages such
as lymphocytes or monocytes. IPSCs derived from the
three storage conditions showed the typical compact
morphology seen in undifferentiated human embryonic
stem cells (hESCs) (Figure 2B). Taken together, these results
indicate that up to 48 hr blood storage at room tempera-
ture is compatible with immediate reprogramming but
can affect the efficiency of IPSC derivation.
Freezing and Thawing of PBMCs Has No Effects on
Conversion to Erythroblasts and Reprogramming into
hIPSCs
To exclude the possibility that freezing and thawing of
PBMCs might have an effect on reprogramming, we next
performed experiments whereby PBMCs isolated fromuthors
donor 1 and donor 2 stored at room temperature for 5 hr
immediately cryopreserved in liquid nitrogen. One month
later, PBMCs were thawed, expanded to erythroblasts,
and reprogrammed into IPSCs (Figure 2C). Importantly,
the number of IPSC colonies formed was comparable prior
to PBMC freezing (i.e., for samples kept at room tempera-
ture for 5 hr) (Figure 2A). IPSCs were also derived from
PBMC samples processed 48 hr postdraw that had been
stored in liquid nitrogen for 1 and 4 months prior to
expansion and reprogramming (Figure S2). Thus, our data
suggest that adding a freezing and thawing cycle of
PBMC samples does not affect the efficiency of subsequent
reprogramming.
Increasing the Number of Input Cells and Virus
Transduction Volume Rescue Reprogramming
Potential of Blood Samples Kept at Room Temperature
for 24 and 48 hr
The results above suggest that whole blood samples deteri-
orate over a period of time at room temperature and hence
decrease the fraction of erythroblasts available for reprog-
ramming (Figure 2A). Therefore, scaling up input target
cells and/or virus transduction volume may improve re-
programming efficiencies of those samples. To test this hy-
pothesis, we next performed experiments in which PBMCs
derived from two donor samples held at room temperature
for 5, 24, and 48hr were cultured in media favoring expan-
sion into erythroblasts. Triple staining was performed
following expansion with surface markers such as CD71
and CD36 to identify erythroblasts population and CD14
for monocyte population and analyzed expression by
flow cytometry. Consistent with our findings in (Figures
1B and 1C), erythroblast populations were also enriched
in donor 3 and donor 4 with 88.2% and 50.9%, respec-
tively, when samples are held at room for 5 hr postdraw
as judged by CD 71 and CD36 double positives. These pop-
ulations dramatically decrease when blood samples were
stored at room temperature for 24 and 48 hr (Figures 3A
and 3B). The vast majority of expanded cells were negative
for CD14 monocyte-specific marker. In marked contrast,
CD14 was expressed in PBMC parental populations, and
CD71 expression was not detected in vast majority of the
cells (Figures S3 and S4). These results indicate that the ma-
jority of expanded cells were erythroblasts.
We doubled the quantity of enriched population of
erythroblasts (1 3 106 cells) and virus volume (MOI 12)
for reprogramming and observed a dramatic improvement
in the IPSC colony formation with up to 3- and 5-fold
(donor 3) and 15- and 6-fold (donor 4) at 24- and 48-hr
stability points, respectively (Figures 3C and 3D). The col-
onies derived from the three storage conditions show the
typical compact IPSC morphology, similar to undifferenti-
ated hESCs (Figure 3E).Stem CellThese results demonstrate that increasing the number of
target cells and virus transduction volumes enhances the
efficiency of IPSC derivation from blood samples stored at
room temperature for up to 48 hr postcollection.
In Vitro Differentiation of hIPSCs
We next examined the pluripotency and differentiation
properties of three IPSC donors derived from the three stor-
age conditions (n = 2–3 lines per donor). Briefly, hIPSCs
were individually picked and expanded for approximately
15–30 passages. The resulting hIPSCs were cultured under
conditions favoring the formation of cells of the three
germ layers, subsequently immunostained with markers
specific for the pluripotency and the three germ layers,
and then analyzed on a Cellomics Array scan. Represen-
tative images of one IPSC donor (donor 1) are shown in
Figures 4 and S5. These analyses show that, prior to the
initiation of cell differentiation, all of our derived IPSC
lines expressed pluripotent markers such as OCT4,
NANOG, and SOX2, thereby confirming their pluripotent
status. After several days in respective differentiation me-
dia, cells were positive for endoderm (SOX17, CXCR4,
GATA4), mesoderm (BRACHYURY, EOMES, MIX1L), and
neuroectoderm (NESTIN, SOX1, SOX2), indicating their
differentiation into all three germ layers. Quantification
of the three differentiation lineages using Cellomics
Array software showed that the markers for endoderm,
mesoderm, and neuroectoderm were upregulated (Fig-
ure 5). On the other hand, OCT4, a pluripotency marker,
was downregulated in the three germ layers. These data
indicate that IPSC derived from blood that had been stored
up to 48 hr are pluripotent and can effectively differentiate
into the three germ layers.
Blood Samples Held at Room Temperature for up to
48 hr PostDraw Produce Multiple IPSC Clones with
Stable Genomes
To evaluate whether storage of blood at room tempera-
ture up to 48 hr affects the genomic stability of IPSCs,
karyotype analysis by multiplex fluorescent in situ hybrid-
ization (M-FISH) was performed on hIPSC lines grown
up to 30 passages. We randomly karyotyped metaphases
obtained from six donors (n = 14 IPSC lines) derived
from 5-hr blood storage, four donors (n = 10 IPSC lines)
derived from 24 hr blood storage, and four donors (n =
9 IPSC lines) derived from 48-hr blood storage. At least
ten metaphase spreads were analyzed per line. M-FISH re-
vealed two normal male karyotypes [46,XY] (Figures 6A
and 6B) and one female karyotype [46,XX] (Figure 6C).
Of the 14 lines derived from 5-hr blood storage, four
lines displayed chromosomal aberrations (Table S1),
i.e., 2.1% abnormal karyotypes of the total 190 meta-
phases analyzed and 29% of the lines karyotyped harborReports j Vol. 5 j 660–671 j October 13, 2015 j ª2015 The Authors 663
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Figure 3. Reprogramming of Erythroblasts-Enriched Populations by Doubling the Input Cells and Viral Transduction Volumes
(A and B) Representative flow cytometry data of donor 3 and donor 4 (linked to Figures S3 and S4).
(C and D) Representative images show AP stained IPSC colonies derived from samples that had been held at room temperature for
5-, 24-, and 48 hr postdraw and reprogramming efficiencies quantified by determining the percentage of AP-positive colonies.
(E) Representative phase contrast images of IPSCs with characteristic typical human ES cell-like morphology in all the three stability time
points are shown. Donor 3 (guuo), donor 4 (sefg). Scale bars represent 250 mm.mutations (Figure 6D). Of the ten lines derived from 24-hr
blood storage, one line had a translocation (Table S1); i.e.,
0.62% abnormal karyotypes of the total 160 metaphases664 Stem Cell Reports j Vol. 5 j 660–671 j October 13, 2015 j ª2015 The Aanalyzed and 10% of the lines karyotyped harbor muta-
tions (Figure 6D). Finally, we analyzed 130 metaphases
from nine IPSC lines derived from 48-hr blood storageuthors
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Figure 4. Characterization of hIPSC Lines
Derived from Blood Samples Stored at
Room Temperature for 5-, 24-, and 48 hr
Postcollection
IPSCs derived from the three storage con-
ditions were cultured in media favoring
differentiation into the three germ layers
and subsequently co-stained with DNA dye
(DAPI) and antibodies against markers for
endoderm, mesoderm, and neuroectoderm.
Expression was analyzed on a Cellomics
array scan. Representative images show
immunofluorescence staining for markers
for pluripotency (OCT4, SOX2, NANOG in
green), endoderm (SOX17, CXCR4, GATA4 in
green), mesoderm (BRACHYURY, EOMES,
MIXL1 in green), neuroectoderm (SOX1,
SOX2, NESTIN in green), and merged images
are shown in Figure S5. The same micro-
scopic fields are shown in Figures 4 and S5.
Donor 1 (IPSC lines: codr_3, codr_5,
codr_7). Scale bars represent 250 mm.and identified two abnormal karyotypes (Table S1),
1.5% aberrant chromosomes of the total 130 metaphases
analyzed and 22% of the lines karyotyped harbor muta-
tions (Figure 6D). Taken together, our data suggest no
dramatic incidence of chromosomal aberrations in IPSCs
derived from blood samples stored at room temperature
for 48 hr postcollection when compared with blood sam-
ples held at room temperature for 5 hr.
Increasing the Virus Transduction Doses Does Not
Delay the Vector Clearance in Reprogrammed Cells
SeV reprogramming vectors tend to decrease over time in
reprogrammed cells after several passages (Fusaki et al.,
2009; Schlaeger et al., 2015). We next investigated how
quickly the SeV RNA was lost during hIPSC expansion
and whether reprogramming with increased virus trans-
duction will delay viral clearance from the cells. Notably,
residual Sendai transcripts were eliminated in 12 of 14
lines tested, including the samples that had been reprog-
rammed with viral MOI 12 (Figure 6E). Residual transcripts
were observed in two lines reprogrammed with MOI 6
that had been derived from donor 1 (lane 1) and donor 2Stem Cell(lane 5) even after up to 26 passages. This may be due to
the variation of vector replication between cell lines (Fusaki
et al., 2009). No RNA transcript was found in lines reprog-
rammed with virus at MOI 12 derived from donor 3 and
donor 4. Taken these findings together, increasing the virus
dose apparently does not delay vector clearance in reprog-
rammed cells.DISCUSSION
Whole-blood and skin-punch biopsies are the most com-
mon tissues used for reprogramming to hIPSCs. One of
themajor challenges faced by clinical centers when collect-
ing these biological samples for use in hIPSC production
is how to minimize the potential tissue degradation asso-
ciated with sample transportation and storage. Several
groups have derived IPSCs from blood samples and recom-
mend a 2- to 4-hr time elapse between biological sample
collection and processing in order to preserve the integ-
rity of primary cells prior to reprogramming (Daheron
and D’Souza 2008; Yang et al., 2008; Freisleben et al.,Reports j Vol. 5 j 660–671 j October 13, 2015 j ª2015 The Authors 665
Figure 5. Characterization of hIPSC Lines
Derived from Blood Samples Stored at
Room Temperature for 5-, 24-, and 48 hr
Postcollection
IPSCs derived from the three storage con-
ditions were cultured in media favoring
differentiation into the three germ layers
and subsequently co-stained with DNA dye
(DAPI) and antibodies against markers for
endoderm, mesoderm, and neuroectoderm.
Expression was analyzed on a Cellomics
array scan. Representative data show the
quantification of pluripotency and differ-
entiation capacity of the IPSC lines ob-
tained from Cellomics Array scan software
(mean ± SD; n = 2 wells)2011; Sommer et al., 2012). However, this will highly be
dependent on the availability of relevant equipment, re-
agents, and trained personnel required for blood sample
processing within the surgical suites.
For clinics with rural study sites with limited labora-
tory facilities that are not adequately equipped to pro-
cess samples, long periods of transportation of samples
to research laboratories, up to several hours, may be
required.
To the best of our knowledge, nevertheless, no pub-
lished data are available on the effects of the long-term
stability of blood stored at room temperature on their
ability to reprogram into IPSCs. Our study demonstrates
that it is possible to store blood samples at room temper-
ature for up to 48 hr before successfully reprogramming
them into IPSCs.
This removes the need for sample processing within 2
to 4 hr of collections. Although the reprogramming
efficiencies seen in IPSC derivation from blood at 24- and
48 hr storage time points was diminished when compared
with fresh blood samples, we always obtained sufficient
colonies required for further studies. Furthermore, the
resulting hIPSC lines display a normal capacity of self-
renewal and ability to differentiate into derivatives of the
three primary germ layers. Importantly, it should be
mentioned that similar results were obtained with samples
collected from patients with rare disease (data not shown).
Therefore, the results described here could be extended to a
diversity of samples.666 Stem Cell Reports j Vol. 5 j 660–671 j October 13, 2015 j ª2015 The AThe genomic stability of hIPSCs has been extensively
studied since this could be a major limitation for clinical
applications (Aasen et al., 2008). Factors that affect the
genomic integrity of stem cells include culture conditions,
number of passages, and enzymatic and non-enzymatic
dissociation (Mitalipova et al., 2005; Martins-Taylor
et al., 2011; Taapken et al., 2011; Nguyen et al., 2013).
However, it was unclear whether long-term incubation
of tissue samples at room temperature over increasing
period of time could impose a survival pressure on the
somatic cells of the tissues and hence affect the quality
of IPSCs derived from them. Notably, karyotype analysis
of our blood derived IPSC lines clearly show that the
rates of small chromosome abnormalities detected in the
three storage conditions are similar to each other and
no notable differences are seen. The karyotypic changes
observed in our lines are deletions, translocation, and tri-
somies involving chromosomes 3, 7, 13, 20, 21, and X
(Table S1). Interestingly, chromosome 20, 21 and chromo-
some X aberrations are known to be predominant for
hESCs and hIPSCs (Martins-Taylor et al., 2011; Taapken
et al., 2011). Therefore, 48 hr of storage of blood samples
at room temperature does not affect the fundamental
characteristic of subsequent hIPSC lines. Our findings sug-
gest that storage up to 48 hr has no detrimental impact on
the genome integrity.
In conclusion, the results from this study suggests that
high-quality IPSCs can be derived from blood samples
kept at room temperature for up to 48 hr, thus enablinguthors
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Figure 6. Screening for Genomic Integrity and SeV Clearance in
IPSCs Derived from Blood Samples Stored at Room Temperature
for 5-, 24-, and 48 hr Postcollection
M-FISH karyotypic analysis was performed on IPSCs derived from
blood to evaluate the effect of storage duration (5-, 24-, 48 hr
postdraw) on genomic stability. Randomly selected metaphases
(10 or 20) were karyotyped on M-FISH and DAPI banding patterns.
(A and B) M-FISH shows normal diploid 46, XY male karyotypes at
passage 20.
(C) Normal diploid 46, XX female karyotype at passage 20. Donor 1
(IPSC lines: codr_3, codr_5, codr_7), donor 2 (IPSC lines: gabq_2,
gabq_4, gabq_6), donor 3 (IPSC lines: guuo_2, guuo_5, guuo_8).
(D) Table displaying the number of lines karyotyped, normal, and
metaphases detected (related to Table S1). Abnormalities met the
Stem Cellsample collections from trial sites distance away from the
research laboratories.EXPERIMENTAL PROCEDURES
Ethics Statement
Human peripheral blood used in this study was approved by NRES
Committee London-Fulham reference number 14/LO/0345. All
subjects were informed of the purpose of the study, and a written
consent was obtained.
Cell Culture
The hIPSCs were grown on irradiated mouse embryonic fibroblast
(MEF) feeders (Globalstem) using stem cell media described below:
AdvancedDMEM(Life technologies) was supplemented as follows:
10% Knockout Serum Replacement (KoSR, Life Technologies),
2 mML-glutamine (Life technologies), 0.007% 2-mercaptoethanol
(Sigma-Aldrich), 4 ng/ml of recombinant zebrafish basic Fibroblast
Growth Factor-2 (CSCR, University of Cambridge), and 1% Pen/
Strep (Life Technologies). Media were changed daily, and the
cells were passaged every 5 to 7 days depending on the confluence
of the plates.
Processing Whole Blood Samples
Human blood samples were collected in sodium citrate collec-
tion tubes from consented individuals from Clinical Trials
Laboratory Services London (CTLS). The age and gender of the
donors are shown in Table S3. Blood samples were held at
room temperature for 5-, 24-, or 48 hr postcollection, and subse-
quently peripheral blood mononuclear cells (PBMCs) were sepa-
rated by using Ficoll-Paque PLUS (GE Healthcare) gradient
centrifugation (Vissers et al., 1988). Briefly, 10 ml from each
blood donor sample (n = 7) was diluted with 10 ml of Dulbecco’s
PBS and layered onto a Ficoll-Paque density gradient according
to the manufacturer’s instructions. The samples were centri-
fuged at 500 3 g for 30 min at room temperature with the brake
off so that the centrifuge speed decelerated slowly after the
elapsed time. The PBMCs were carefully collected from the inter-
phase and transferred into a fresh 50 ml Falcon tube, and PBS
was added up to total volume of 50 ml. Cells were centrifuged
at 300 3 g for 20 min with the brake on, and the PBMC cell
pellets were either frozen down in freezing media (ice cold) con-
sisting of 10% DMSO and 90% complete KOSR media (and
transferred into liquid nitrogen) or used directly for expansion
into erythroblasts.International System for Human Cytogenetics Nomenclature
(2013).
(E) Loss of SeV RNA was detected by RT-PCR. SeV RNA clearance
was seen in majority of lines except in two cases (D1 and D2)
where viral RNA persisted over several passages up to p26.
PBMC_SeV (), non-reprogrammed human PBMCs; DDW, double-
distilled water; SeV (+), human erythroblasts reprogrammed
with SeV at MOI 6 and RNA extracted at passage 2. D1–D6 indicate
donor IPSC lines. b-actin was included as internal control (see also
Table S2).
Reports j Vol. 5 j 660–671 j October 13, 2015 j ª2015 The Authors 667
Expansion of PBMCs into Erythroblasts
Following the PBMC separation as described above, samples
were cultured in media favoring expansion into erythroblasts as
described by Yang et al. (2008) and Soares et al. (2015) with mod-
ifications. Briefly, 2 3 106 PBMCs (frozen or fresh) samples were
cultured in a well of a 12-well culture plate in 2 ml of serum-free
expansion media (EM) containing StemSpan H3000 (SS, StemCell
Technologies), SCF (100 ng/ml, R&D Systems), IL-3 (10 ng/ml, Life
Technologies), erythropoietin (3 U/ml; Miltenyi Biotech), IGF-1
(40 ng/ml; Miltenyi Biotech), and dexamethasone (1 mM; Sigma-
Aldrich) for 9 days. Spent media were changed every 3 days. After
that, cells were analyzed by flow cytometry to monitor erythro-
blast expansion using antibodies specific for erythroblast cell
surface markers CD71 and CD36 and PBMC cell surface marker
CD14 as described below.
Flow Cytometry Analysis
Flow cytometric experiments were performed using a BD LSR
Fortessa cell analyzer. Briefly, at day 9 of PBMC expansion, 5%
of cell population was either dual or triple stained for 20 min
at room temperature with PE-labeled anti-CD71 (BD Biosciences,
UK, #555537), APC-labeled anti-CD36 (BD Biosciences, UK,
#561822), and FITC-labeled anti-CD14 (BD Biosciences, UK,
#561712) resuspended in PBS containing 0.5% BSA, 2 mM EDTA
1% PFA. Isotype controls IgG2a,k, IgM,k, and IgG2a,k were used
as negative controls for FACS gating for PE-labeled anti-CD71,
APC-labeled anti-CD36, FITC-labeled anti-CD14, respectively,
and single-color stained cells for compensation. Following the
flow cytometric assays, a postacquisition analysis was subse-
quently performed using FlowJo software V10 (Tree Star).
Reprogramming of Erythroblast-Enriched Cell
Populations Using Sendai Virus
For IPSC derivation from blood, Sendai vectors (each) expressing
human OCT3/4, SOX2, KLF4, and c-MYC (CytoTune, Life Tech-
nologies, catalog number A1377801) were used to infect erythro-
blast-enriched populations following expansion. Briefly, 5 3 105
(or 1 3 106) erythroblast-enriched populations were resuspended
in 0.3ml (or 1.2ml) EMmedia in a 15-ml Falcon tube, respectively.
After that, Sendai virus vectors were reconstituted at MOI 6
(or MOI 12) in 15-ml Falcon tube containing 0.3-ml (or 1.2-ml)
EMmedia supplemented with 8-mg polybrene, respectively. Subse-
quently, virus suspension was added to the cells in 15-ml falcon
tube and resuspended and transferred into a 12-well plate. Cells
were incubated overnight at 37C and 5% CO2. Next day cells
were collected in a 15-ml falcon tube and washed with SS media
by centrifugation at 300 3 g for 5 min with brake on. The trans-
duced cell pellets were resuspended in 2-ml EM media and trans-
ferred into a well of 12-well plate. Three days postinfection, cells
in a well of a 12-well plate were transferred to a 10-cm culture
dish containing mouse embryonic fibroblast (MEF) feeder layer
and cultured further for 2 days in EM media. Starting from day 5
posttransduction, cells were maintained in IPSC media (KoSR +
FGF2), and media were changed daily. At 10 to 21 days posttrans-
duction, the transduced cells began to form colonies with IPSC
morphology, and visible colonies were handpicked and transferred
onto 12-well MEF feeder plates.668 Stem Cell Reports j Vol. 5 j 660–671 j October 13, 2015 j ª2015 The APassaging of hIPSCs
To passage hIPCS, cells were washed with PBS and incubated with
Collagenase and Dispase (Collagenase IV 1 mg/ml, Invitrogen
17104-019; Dispase 1 mg/ml, Invitrogen 17105-041) for 45 min.
Colonies were collected in a falcon tube containing IPSC growth
medium and were allowed to sediment for 30 s. The supernatant,
containing residual Collagenase/Dispase was removed, and the
colonies washed once with IPSC medium. The colonies were al-
lowed to sediment again and the supernatant removed. Finally,
they were mechanically broken up and plated onto fresh MEF
feeders. Cells were passaged every 5 to 7 days (depending on the
confluence of the plates) at the desired ratio.
AP Staining
Following reprogramming, cells were fixed in 4% paraformalde-
hyde and subsequently stained for AP with the AP BCIP/NBT
ALP staining kit as recommended by the manufacturer (Promega).
hIPSCs Differentiation
Differentiation was performed as described previously (Vallier
et al., 2009). Briefly, hIPSCs grown on feeder conditions were
harvested using Collagenase and Dispase. The colonies were
collected, washed in media, and mechanically broken up before
being replated onto 24-well MEF feeder plates or precoated gela-
tine/FBS plates. For pluripotency assays, colonies were seeded on
MEF feeder plates and for the differentiation assay colonies were
grownon gelatine/FBS plates. Prior to differentiation tomesoderm,
endoderm, and neuroectoderm, cells were cultured overnight in
predifferentiation media CDM-PVA supplemented with recombi-
nant ACTIVIN-A (10 ng/ml; CSCR, University of Cambridge) and
zebrafish FGF2 (12 ng/ml; CSCR, University of Cambridge). For
differentiation into mesoderm following culture in prediffer-
entiation media, spent media were removed and replaced with
fresh CDM-PVA media containing bone morphogenic protein 4
(BMP4, 10 ng/ml, R&D Systems), FGF2 (20 ng/ml; CSCR, Univer-
sity of Cambridge), recombinant ACTIVIN-A (10 ng/ml; CSCR,
University of Cambridge), LY29004 (10 mM, Promega), and
CHIR99021 (5 mM, Selleckchem) and subsequently cultured for
3 days. Media were changed daily.
For differentiation into endoderm following culture in prediffer-
entiation, cells were cultured further in differentiation media for
3 days. Briefly, day 1 spent media were removed and replaced
with fresh CDM-PVA media supplemented with recombinant
ACTIVIN-A (100 ng/ml; CSCR,University of Cambridge), zebrafish
FGF2 (80 ng/ml; CSCR, University of Cambridge), BMP4 (10 ng/ml
R&D Systems), LY29004 (10 mM), and CHIR99021 (3 mM). Day 2
media were removed and replaced with fresh CDM-PVA supple-
mented with recombinant ACTIVIN-A (100 ng/ml), zebrafish
FGF2 (80 ng/ml), BMP4 (10 ng/ml), and LY29004 (10 mM). Day 3
mediawere removed and replacedwith RPMImedia supplemented
with B27 (13, Life Technologies), recombinant ACTIVIN-A
(100 ng/ml), zebrafish FGF2 (80 ng/ml), and Non-Essential Amino
Acids (13, Life Technologies).
For differentiation to neuroectoderm, IPSCs were grown for
12 days in CDM-PVA supplemented with SB431542 (10 mM; Tocris
Bioscience), FGF2 (12 ng/ml, CSCR University of Cambridge), and
NOGGIN (150 ng/ml, R&D Systems). Media were changed daily.uthors
Immunostaining
For the detection of pluripotency and differentiation markers,
cells grown in 24-well plates as described above were fixed with
4% paraformaldehyde for 20 min. After that, cells were permeabi-
lized and blocked with 10% donkey serum and 0.1% Triton X-100
in PBS. Subsequently, cells were stained with primary antibodies
overnight at 4C and finally incubated with Fluorochrome-labeled
secondary antibodies ALEXA FLUOR (Invitrogen). The primary an-
tibodies used for detecting pluripotency markers were anti-OCT4
(SC-5279, Santa Cruz Biotech), anti-SOX2 (AF2018, R&D), and
anti-NANOG (AF1997, R&D). The primary antibodies used for
detecting endoderm markers were anti-SOX17 (AF1924, R&D),
anti-CXCR4 (MAB173-100, R&D), and anti-GATA4 (SC-25310,
Santa Cruz Biotech). The primary antibodies used for detecting
mesoderm markers were anti-Brachyury (AF2085, R&D), anti-
EOMES (Ab23345, Abcam), and anti-MIXL1 (SC-98664, Santa
Cruz Biotech). The primary antibodies used for detecting neuroec-
toderm markers were anti-NESTIN (AB22035, Abcam), and anti-
SOX1 (AF3369, R&D) anti-SOX2 (AF2018, R&D). The secondary
antibodies usedwere donkey anti-goat AF488 (Invitrogen), donkey
anti-mouse AF488 (Invitrogen), and donkey anti-rabbit AF488
(Invitrogen). Images were captured and quantified using a Cello-
mics array scan, and images were processed using Adobe Photo-
shop CS5.Chromosome Harvest and Multiplex-FISH
Karyotyping of Human IPSCs
Metaphase chromosomes fromhIPSCswere harvested as described
previously (Moralli et al., 2011), with slight modifications. Briefly,
after refreshing, the medium cells were treated with 10 mM ROCK
inhibitor (Tocris) for 2–3 hr, followed by incubation with 25–
100 ng/ml Nocodazole (Sigma-Aldrich) for a further 2–3 hr. Subse-
quently, cells were dissociated using Accutase (Sigma-Aldrich) and
treated with a buffered hypotonic solution (0.4% KCl in 10 mM
HEPES [pH 7.4]) for 8–12 min at 37C. The cells were then fixed
and washed twice in a 6:1 (v/v) methanol:glacial fixative and
kept in fixative in 20C freezer until use.
For multiplex-fluorescence in situ hybridization (M-FISH), chro-
mosome-specific DNA libraries were generated from 5,000 copies
of flow-sorted chromosomes, provided by Flow Cytometry Core
Facility of theWellcome Trust Sanger Institute, using GenomePlex
Whole Genome Amplification (WGA2) kit (Sigma-Aldrich). Hu-
man 24-color painting probe was made following the pooling
strategy (Geigl et al., 2006). Five human chromosome pools were
labeled with ATTO 425-, ATTO 488-, CY3-, CY5-, and Texas Red-
dUTPs (Jena Bioscience), respectively, using WGA 3 re-amplifica-
tion kit (Sigma-Aldrich) as described before (Gribble et al., 2013).
The labeled products were pooled and sonicated to achieve a size
range of 200–1,000 bp, optimal for use in chromosome painting.
Then the sonicated DNA sample was precipitated with ethanol
together with human Cot-1 DNA (Invitrogen) and resuspended
in a hybridization buffer (50% formamide, 2 3 SSC, 10% dextran
sulfate, 0.5 M phosphate buffer, 1 3 Denhardt’s solution [pH
7.4]). Metaphase preparations were dropped onto precleaned
microscopic slides followed by fixation in acetone (Sigma-Aldrich)
for 10 min and dehydration through an ethanol series (70%, 90%,
and 100%).Metaphase spreads on slideswere denatured by immer-Stem Cellsion in an alkaline denaturation solution (0.5 M NaOH, 1.0 M
NaCl) for 50–60 s, followed by rinsing in 1M Tris-HCl (pH 7.4)
solution for 3 min, 1 3 PBS for 3 min, and dehydration through
a 70%, 90%, and 100% ethanol series. The M-FISH probe was
denatured at 65C for 10 min before being applied onto the dena-
tured slides. The hybridization area was sealed with a 223 22-mm
coverslip and rubber cement. Hybridization was carried out in
a 37C incubator for 2 nights. The posthybridization washes
included a 5-min stringent wash in 0.5 3 SSC at 75C, followed
by a 5-min rinse in 2 3 SSC containing 0.05% Tween20 (VWR)
and a 2-min rinse in 1 3 PBS, both at room temperature. Finally,
slides were mounted with SlowFade Gold mounting solution con-
taining 406-diamidino-2-phenylindole (Invitrogen). Images were
visualized on a Zeiss AxioImager D1 fluorescentmicroscope equip-
ped with narrow band-pass filters for DAPI, DEAC, FITC, CY3,
TEXAS RED, and CY5 fluorescence and an ORCA-EA CCD camera
(Hamamatsu). M-FISH digital images were captured using the
SmartCapture software (Digital Scientific) and processed using
the SmartType Karyotyper software (Digital Scientific). Approxi-
mately 10–20 metaphase chromosomes per IPSC line were fully
karyotyped.Screening for SeV Clearance by RT-PCR
Total RNA was extracted from cells using Gen Elute Mammalian
Total RNA Miniprep Kit reagent (catalog number RTN70, Sigma-
Aldrich) with On-Column DNase I Digestion Set (catalog number
DNASE70, Sigma-Aldrich). RT-PCR reactions were performed using
SuperScript III Reverse Transcriptase (catalog number 18080-044,
Invitrogen), and Random Primers (catalog number C1181, Prom-
ega) with 0.5 mg of total RNA per reaction. Total RNA was quanti-
fied using a NanoDrop ND-1000. PCR was performed with 1 ml
of cDNA in 50 ml of Platinum Taq DNA Polymerase mix (catalog
number 10966-034, Invitrogen) according to manufacturer’s
recommendation. For SeV PCR the following condition was
used: denaturation 95C, 30 s, annealing: 55C, 30 s, elongation:
72C, 30 s, for 35 cycles. The expected size of the PCR product
is 181 bp.
The primer pair used for the detection of presence of Sendai virus
vector has been previously described (Fusaki et al., 2009), and the
sequences are shown in Table S2. Beta-actin primer pair used in this
study has been previously described (Fischer et al., 2014), and the
sequences are shown in Table S2. The expected size of the PCR
product is 100 bp.
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